Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis

In conclusion, the approved regimen for China achieved adequate target attainment for all pathogens typically associated with these infections. The higher oral exposure observed in Asians may enhance efficacy without affecting safety or tolerability.